These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Gilles de la Tourette's syndrome: effects of stimulant drugs. Erenberg G; Cruse RP; Rothner AD Neurology; 1985 Sep; 35(9):1346-8. PubMed ID: 2862607 [TBL] [Abstract][Full Text] [Related]
23. Visual feedback of own tics increases tic frequency in patients with Tourette's syndrome. Brandt VC; Lynn MT; Obst M; Brass M; Münchau A Cogn Neurosci; 2015; 6(1):1-7. PubMed ID: 25185800 [TBL] [Abstract][Full Text] [Related]
24. [Gilles de la Tourette's syndrome: a particular clinical form of tics? A case report]. Legrand F; Dufour C Bull Soc Sci Med Grand Duche Luxemb; 1997; 134(1):13-9. PubMed ID: 9303821 [TBL] [Abstract][Full Text] [Related]
25. GILLES DE LA TOURETTE'S SYNDROME. ELLISON RM Med J Aust; 1964 Feb; 1():153-5. PubMed ID: 14118203 [No Abstract] [Full Text] [Related]
26. Premonitory urges as "attentional tics" in Tourette's syndrome. Kane MJ J Am Acad Child Adolesc Psychiatry; 1994; 33(6):805-8. PubMed ID: 8083137 [TBL] [Abstract][Full Text] [Related]
27. A prospective longitudinal study of Gilles de la Tourette's syndrome. Carter AS; Pauls DL; Leckman JF; Cohen DJ J Am Acad Child Adolesc Psychiatry; 1994; 33(3):377-85. PubMed ID: 8169183 [TBL] [Abstract][Full Text] [Related]
28. Gilles de la Tourette's disease. SINGER K Am J Psychiatry; 1963 Jul; 120():80-1. PubMed ID: 13977606 [No Abstract] [Full Text] [Related]
29. Gilles de la Tourette's syndrome: biochemical approaches. Van Woert MH; Jutkowitz R; Rosenbaum D; Bowers MB Res Publ Assoc Res Nerv Ment Dis; 1976; 55():459-65. PubMed ID: 1070064 [TBL] [Abstract][Full Text] [Related]
30. Objective assessments of longitudinal outcome in Gilles de la Tourette's syndrome. Pappert EJ; Goetz CG; Louis ED; Blasucci L; Leurgans S Neurology; 2003 Oct; 61(7):936-40. PubMed ID: 14557563 [TBL] [Abstract][Full Text] [Related]
31. Adult tics in Gilles de la Tourette's syndrome: description and risk factors. Goetz CG; Tanner CM; Stebbins GT; Leipzig G; Carr WC Neurology; 1992 Apr; 42(4):784-8. PubMed ID: 1565232 [TBL] [Abstract][Full Text] [Related]
32. Psychodynamic considerations in Gilles de la Tourette's disease, maladie des tics, with a report of 5 cases and discussion of the literature. ASCHER E Am J Psychiatry; 1948 Oct; 105(4):267-76. PubMed ID: 18883843 [No Abstract] [Full Text] [Related]
33. Late onset startle induced tics. Tijssen MA; Brown P; Morris HR; Lees A J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):782-4. PubMed ID: 10567498 [TBL] [Abstract][Full Text] [Related]
34. [On a case of tics (Gilles de la Tourette's disease) treated with heloperidol]. Stanciu E; Csiky K; Csiky C Neurol Psihiatr Neurochir; 1972; 17(1):43-8. PubMed ID: 4502925 [No Abstract] [Full Text] [Related]
35. TOURETTE'S DISEASE: SYMPTOMATIC RELIEF WITH HALOPERIDOL. CHAPEL JL; BROWN N; JENKINS RL Am J Psychiatry; 1964 Dec; 121():608-10. PubMed ID: 14239470 [No Abstract] [Full Text] [Related]
36. Six cases of Gilles de la Tourette's syndrome. Fernando SJ Br J Psychiatry; 1976 May; 128():436-41. PubMed ID: 1064460 [TBL] [Abstract][Full Text] [Related]
37. Distinct structural changes underpin clinical phenotypes in patients with Gilles de la Tourette syndrome. Worbe Y; Gerardin E; Hartmann A; Valabrégue R; Chupin M; Tremblay L; Vidailhet M; Colliot O; Lehéricy S Brain; 2010 Dec; 133(Pt 12):3649-60. PubMed ID: 20959309 [TBL] [Abstract][Full Text] [Related]
38. The use of methylphenidate and imipramine in Gilles de la Tourette's disease in children. Fras I; Karlavage J Am J Psychiatry; 1977 Feb; 134(2):195-7. PubMed ID: 264771 [TBL] [Abstract][Full Text] [Related]
39. Costs of control: decreased motor cortex engagement during a Go/NoGo task in Tourette's syndrome. Thomalla G; Jonas M; Bäumer T; Siebner HR; Biermann-Ruben K; Ganos C; Orth M; Hummel FC; Gerloff C; Müller-Vahl K; Schnitzler A; Münchau A Brain; 2014 Jan; 137(Pt 1):122-36. PubMed ID: 24176975 [TBL] [Abstract][Full Text] [Related]